Who
Deepak Srivastava
Director
Company insider
Files Form 4 as: Director, Tenaya Therapeutics.
In numbers
- Trades disclosed
- 7
- Buys
- 1
- Sells
- 0
- Bought
- $600K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 10 Jun 2022
- Last trade
- 28 May 2026
- Last filed
- 29 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 28 May 2026filed 29 May 2026 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 28 May 2026filed 29 May 2026 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —120,000 at $0.00 | filing |
| 29 May 2025filed 30 May 2025 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —107,400 at $0.00 | filing |
| 18 Oct 2024filed 21 Oct 2024 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —34,000 at $0.00 | filing |
| 9 Jun 2023filed 12 Jun 2023 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,532 at $0.00 | filing |
| 21 Nov 2022filed 9 Dec 2022 | TNYA Tenaya TherapeuticsBiotechnology | SEC FORM 4 Bought | $600K230,769 at $2.60 | filing |
| 10 Jun 2022filed 13 Jun 2022 | TNYA Tenaya Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —39,727 at $0.00 | filing |
News
Tenaya Therapeutics (NASDAQ:TNYA) versus Sutro Biopharma (NASDAQ:STRO) Head-To-Head ComparisonTNYA · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Deepak Srivastava; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.